z-logo
open-access-imgOpen Access
Issue Information
Publication year - 2017
Publication title -
molecular oncology
Language(s) - Uncategorized
Resource type - Reports
SCImago Journal Rank - 2.332
H-Index - 88
eISSN - 1878-0261
pISSN - 1574-7891
DOI - 10.1002/1878-0261.12002
Subject(s) - sorafenib , citation , library science , information retrieval , computer science , medicine , hepatocellular carcinoma , cancer research
Dual inhibition of Akt and c‐Met as a second‐line therapy following acquired resistance to sorafenib in hepatocellular carcinoma cells, by P. Han et al . (pp. 320–334).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom